industry knowledge and experience

The biopharma industry is rapidly evolving. Drug developers need future-focused partners to stay ahead of the curve.

Ambit’s consulting practices offer cutting-edge expertise in rare and specialty disease, empowering the biopharma industry to deliver innovative therapies and win as the market continues to evolve.
Seamlessly move from strategy to execution with a consulting partner that can provide holistic support and operationalize strategic insights. With decades of biopharma industry knowledge and experience, we provide hands-on senior leadership and project teams optimized for your needs.

Our consultants partner with clients to help them fully realize and communicate the value of their innovative assets to all stakeholders: healthcare providers, patients, and payers. We work primarily in specialty therapeutic categories, with a heavy focus on rare diseases.

Focused Expertise

Current state assessment informed by deep biopharma industry knowledge and experience

Ideation

Strategic planning with a focus on landscape trends

Innovation

Detailed roadmap-planning with a pragmatic mindset

Data-Driven Results

Accountable KPI measurement and monitoring

learn more

Contact us to learn more about how we can help you win as the market continues to evolve.

Interested in joining the strategy team?

learn more about open roles on our careers page

Join the team

Meet the strategy team

Aileen Nicoletti directs our Strategy practice. With 20 years of experience in pre-commercial biotech strategy and launch preparation, she has the strategic and scientific expertise to deliver quality insights and strategies well supported by deep market understanding. She cares deeply about building a culture at Ambit that provides the best work for the client and maximizes development of the team.
Aileen Nicoletti
Managing Director
Alex has more than 6 years of life sciences research experience with a focus on virology and immunology. His desire to solve complex problems started during his PhD when he identified and described a novel pro-viral factor for flavivirus transmission found in mosquito saliva.​ ​Prior to joining Ambit, Alex completed his PhD work in Boston, MA during which he worked closely with several startup and early-stage life science companies. He conducted market research, developed corporate and commercial strategies, and built client-tailored business plans across multiple therapeutic areas.​ ​Alex holds a BS in chemistry from the University of North Carolina at Chapel Hill and a PhD in microbiology from Boston University. He currently resides in Chicago, IL and enjoys playing soccer and sailing.
Alex Gold

Consultant

Allie has more than 8 years of experience in engineering and life sciences. Her drive to tackle seemingly unsolvable problems began during her PhD where she developed and patented novel biomaterials to treat spinal cord injury. She took this passion into her career in consulting where she found her niche in rare diseases where few, if any, treatments exist. ​ During her time as a commercial strategy consultant, she gained therapeutic area acumen in rare diseases across gastroenterology, oncology, neurology, and immunology. She has considerable experience executing primary market research and is energized by facilitating insightful discussions with experts and patients ‘on the ground.’ Having the opportunity to create lasting change for patients with high unmet need ‘gets her out of bed in the morning.
Allie Kolberg-Edelbrock
Engagement Manager
Andrew Kuzemczak has more than 3 years of experience in life sciences with a focus on cardiovascular medicine. His drive to improve patient health through medical engineering and entrepreneurship began during his undergraduate years where he developed a healthcare incubator, spinning out 5 companies alongside 10 doctors. Prior to joining Ambit, Andrew conducted multiple years of research as an undergraduate at the Yale Cardiovascular Research Center, uncovering and reversing the growth factor pathway driving pulmonary hypertension. Andrew’s passion for patient health extends beyond the bench, having founded a cardiovascular initiative for indigenous tribes in South America. Andrew is energized by the opportunity to improve human health through all means. Andrew holds a BS in Molecular Biology from Yale and is completing his MS in Biomedical Engineering at Columbia. He was born to Ukrainian immigrants in Morristown, NJ and currently lives in Morris Plains, NJ.
Andrew Kuzemczak

Analyst

Andrew Verbeke is an Engagement Manager within Ambit's Strategy Consulting department. Andrew has ten years of consulting experience, roughly eight of which were spent working in the biopharma industry. Before joining Ambit, Andrew worked previously at ZS Associates, Deloitte, and The Scowcroft Group. Andrew holds an MBA from Kellogg School of Management, an MA from American University, and two bachelors from the University of Connecticut.
Andrew Verbeke
Engagement Manager
Anne-Marie has a background in Life Sciences and Public Health with consulting experience in market access, societal impact, and quality improvement. She is passionate about finding creative solutions to complex problems and leveraging innovative strategies to create tangible benefits for patients and the healthcare industry. While she has developed a range of expertise, her primary interest is in rare disease therapeutics. Anne-Marie holds a BSc in Life Sciences, MHSc in Translational Research, and an MPH in Policy and Management. She was born and raised in Toronto, Canada and currently resides in New York, NY.
Anne-Marie Voyer

Consultant

Barry brings 2+ years of life science and advanced analytics experience to the team. Prior to joining Ambit, Barry gained invaluable quantitative knowledge conducting various pharmacoepidemiology and outcomes research projects at Columbia University and Brown University, collaborating cross-functionally across teams. Beyond the lab, he has experience in life science strategy consulting, performing landscape and strategic positioning assessments across several rare disease indications. Barry holds an MPH from Columbia's Mailman School of Public Health. He currently resides in New York, NY.
Barry Chiu
Analyst